International Clinical Trial: Disease-modifying Efficacy of Sitagliptin Therapy in Early-stage Parkinson's Disease

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07804381) titled 'Disease-modifying Efficacy of Sitagliptin Therapy in Early-stage Parkinson's Disease' on Sept. 1.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Investigator).

Primary Sponsor: Yonsei University

Condition: Parkinson Disease

Intervention: Drug: Sitagliptin

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: December 15, 2026

Target Sample Size: 160

To know more, visit https://clinicaltrials.gov/study/NCT07804381

Disclaimer: Curated by HT Syndicatio...